Investor Alert: Robbins LLP Informs Stockholders of the GSK PLC Class Action
Provided By PR Newswire
Last update: Feb 6, 2025
SAN DIEGO, Feb. 5, 2025 /PRNewswire/ -- Robbins LLP informs stockholders that a class action was filed on behalf of all purchasers of the American Depository Receipts ("ADRs") of GSK PLC (NYSE: GSK) between February 5, 2020 and August 14, 2022. GSK is a global pharmaceutical company that develops, manufactures, and markets vaccines and medicines worldwide.
Read more at prnewswire.com
